Pfizer (PFE) Tops Q1 EPS by 15c, Guidance Misses Consensus
Tweet
Share
E-mail
Get Alerts PFE Hot Sheet
Price: $24.54 -0.16%
Revenue Growth %: -1.9%
Financial Fact:
Less: Net income attributable to noncontrolling interests: 0
Today's EPS Names:
ORPB, ONEG, NDLS, More
Revenue Growth %: -1.9%
Financial Fact:
Less: Net income attributable to noncontrolling interests: 0
Today's EPS Names:
ORPB, ONEG, NDLS, More
Join SI Premium – FREE
Pfizer (NYSE: PFE) reported Q1 EPS of $1.62, $0.15 better than the analyst estimate of $1.47. Revenue for the quarter came in at $25.7 billion versus the consensus estimate of $23.86 billion.
GUIDANCE:
Pfizer sees FY2022 EPS of $6.25-$6.45, versus the consensus of $7.15. Pfizer sees FY2022 revenue of $98-102 billion, versus the consensus of $107.9 billion.
For earnings history and earnings-related data on Pfizer (PFE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gentex Corporation (GNTX) Tops Q2 EPS by 8c ; Offers Guidance
- Boston Beer Co. (SAM) Misses Q2 EPS by 131c ; Offers Guidance
- Community West Bancshares (CWBC) Misses Q2 EPS by 20c
Create E-mail Alert Related Categories
Earnings, Guidance, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
